The DNA Repair Inhibitor DT01 as a Novel Therapeutic Strategy for Chemosensitization of Colorectal Liver Metastasis
暂无分享,去创建一个
M. Dutreix | A. Herbette | A. Denys | N. Herath | F. Devun | Marie-Christine Lienafa | Jian‐sheng Sun
[1] M. Dutreix,et al. A Preclinical Study Combining the DNA Repair Inhibitor Dbait with Radiotherapy for the Treatment of Melanoma , 2014, Neoplasia.
[2] M. Dutreix,et al. Inhibition of DNA damage repair by artificial activation of PARP with siDNA , 2013, Nucleic acids research.
[3] Sameer Al-harthi,et al. Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line , 2012, Cancer Cell International.
[4] P. Schemmer,et al. Treatment of Hepatocellular Carcinoma: A Systematic Review , 2012, Liver Cancer.
[5] E. Barbier,et al. Distribution and Radiosensitizing Effect of Cholesterol-Coupled Dbait Molecule in Rat Model of Glioblastoma , 2012, PloS one.
[6] T. Meyer,et al. Are there opportunities for chemotherapy in the treatment of hepatocellular cancer? , 2012, Journal of hepatology.
[7] M. Dutreix,et al. Preclinical study of the DNA repair inhibitor Dbait in combination with chemotherapy in colorectal cancer , 2012, Journal of Gastroenterology.
[8] M. Dutreix,et al. Comparison of distribution and activity of nanoparticles with short interfering DNA (Dbait) in various living systems , 2011, Cancer Gene Therapy.
[9] K. Vasquez,et al. Quantitative Whole Body Biodistribution of Fluorescent-Labeled Agents by Non-Invasive Tomographic Imaging , 2011, PloS one.
[10] M. Dutreix,et al. Hyperactivation of DNA-PK by Double-Strand Break Mimicking Molecules Disorganizes DNA Damage Response , 2009, PloS one.
[11] Jean-Luc Coll,et al. Small-Molecule Drugs Mimicking DNA Damage: A New Strategy for Sensitizing Tumors to Radiotherapy , 2009, Clinical Cancer Research.
[12] Ricky A. Sharma,et al. DNA repair pathways as targets for cancer therapy , 2008, Nature Reviews Cancer.
[13] S. Benlloch,et al. Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology. , 2006, The Journal of molecular diagnostics : JMD.
[14] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[15] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[16] E. Blakely,et al. Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein. , 2000, Cancer research.
[17] C. Anderson,et al. DNA-PK, the DNA-activated protein kinase, is differentially expressed in normal and malignant human tissues , 1999, Oncogene.
[18] K. Einarsson,et al. Low density lipoprotein receptor-binding activity in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[19] A. Radwan,et al. Targeting cancer using cholesterol conjugates. , 2014, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.
[20] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[21] É. Vinet,et al. Regional treatment of metastasis: surgery of colorectal liver metastases. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.